Jeffrey Stein has bought stock on 9 days since Mar 2017

Jeffrey Stein, Ph.D., age 70, is the President, Chief Executive Officer, and Director of Cidara Therapeutics, Inc. (CDTX), a role he has held since January 2014.( Under his leadership, Cidara focuses on developing novel anti-infective therapies, particularly in the antifungal space to address high unmet needs in invasive fungal infections.(

Stein brings extensive experience in biotechnology and anti-infectives, having previously served as CEO of Trius Therapeutics from its founding in 2007 until its acquisition by Cubist Pharmaceuticals in 2013, where he advanced the antibacterial drug tedizolid to FDA approval.( Earlier, he was a Venture Partner and Kauffman Fellow at Sofinnova Ventures, opening their San Diego office; co-founder and Chief Scientific Officer of Quorex Pharmaceuticals, acquired by Pfizer in 2005; and Principal Scientist at Diversa Corporation and Agouron Institute.( He earned his Ph.D. with graduate work as a NASA Graduate Student Researcher Fellow at UCSD and conducted postdoctoral research as an Alexander Hollaender Distinguished Fellow at Caltech.( Stein also serves on the board of IDEAYA Biosciences and previously Paratek Pharmaceuticals, and is founding Chairman and President of the Antibiotics Working Group.(

Written by Perplexity from public sources.